| P50 | author | Jun Wang | Q50996904 |
| | John F Marshall | Q54324431 |
| | Claude Chelala | Q56435394 |
| | Jude Fitzgibbon | Q60376856 |
| | Prabhu Arumugam | Q86580025 |
| | Ai Nagano | Q89582318 |
| | Aldo Scarpa | Q37392347 |
| | Nick R Lemoine | Q38323533 |
| | Hemant M. Kocher | Q38330856 |
| P2093 | author name string | Thorsten Hagemann | |
| | Syed Haider | |
| | Tatjana Crnogorac-Jurcevic | |
| | Ami Desai | |
| | Laurent Dumartin | |
| P2860 | cites work | Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007 | Q57829118 |
| | Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas | Q57846416 |
| | Association of axon guidance factor Semaphorin 3A with poor outcome in pancreatic cancer | Q60687208 |
| | The human plasma proteome: a nonredundant list developed by combination of four separate sources | Q24304465 |
| | The F-BAR protein NOSTRIN participates in FGF signal transduction and vascular development. | Q24339432 |
| | NCBI GEO: archive for functional genomics data sets--update | Q24595691 |
| | Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes | Q24595981 |
| | DNA synthesis at individual replication forks requires the essential initiation factor Cdc45p | Q24599663 |
| | Core signaling pathways in human pancreatic cancers revealed by global genomic analyses | Q24606006 |
| | Comprehensive molecular characterization of human colon and rectal cancer | Q24630415 |
| | Comprehensive molecular portraits of human breast tumours | Q24630844 |
| | RhoC interacts with integrin α5β1 and enhances its trafficking in migrating pancreatic carcinoma cells | Q27301053 |
| | Integrated genomic analyses of ovarian carcinoma | Q27860518 |
| | Cancer statistics, 2010 | Q27860525 |
| | The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups | Q29614700 |
| | Pancreatic cancer | Q29616288 |
| | The patterns and dynamics of genomic instability in metastatic pancreatic cancer | Q29618121 |
| | Prognostic gene signatures for non-small-cell lung cancer | Q30485836 |
| | Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer | Q30497419 |
| | Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes | Q30989925 |
| | The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins | Q33256124 |
| | Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. | Q33414759 |
| | Intrinsic bias in breast cancer gene expression data sets | Q33475987 |
| | Pancreatic cancer: molecular pathogenesis and new therapeutic targets | Q33899954 |
| | A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma | Q33992146 |
| | Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging? | Q34075815 |
| | DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma | Q34171014 |
| | Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes | Q34276961 |
| | Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays | Q34928555 |
| | Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice | Q35913662 |
| | Physiological analysis of oncogenic K-ras | Q36498721 |
| | Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy | Q37127423 |
| | Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. | Q37252144 |
| | Integrative survival-based molecular profiling of human pancreatic cancer | Q37276948 |
| | Cdc45 is a critical effector of myc-dependent DNA replication stress. | Q37292428 |
| | Advanced pancreatic carcinoma: current treatment and future challenges | Q37681300 |
| | Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic cancer cell invasion | Q37710812 |
| | Molecular therapy of pancreatic cancer. | Q37729800 |
| | Integrins as therapeutic targets: lessons and opportunities | Q37795552 |
| | Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association. | Q38172665 |
| | Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer | Q38429076 |
| | High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway. | Q38498880 |
| | Integrin α5β1 plays a critical role in resistance to temozolomide by interfering with the p53 pathway in high-grade glioma. | Q39347057 |
| | FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. | Q39803380 |
| | R/DWD: distance-weighted discrimination for classification, visualization and batch adjustment | Q42549440 |
| | Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene | Q42739835 |
| | Noise and bias in microarray analysis of tumor specimens | Q45005500 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | limma | Q112236343 |
| P433 | issue | 12 | |
| P921 | main subject | adenocarcinoma | Q356033 |
| | invasive ductal carcinoma | Q1671685 |
| | pancreatic ductal carcinoma | Q8263002 |
| | pancreatic ductal adenocarcinoma | Q18555956 |
| | multi-gene signature | Q105770885 |
| P304 | page(s) | 105 | |
| P577 | publication date | 2014-12-03 | |
| P1433 | published in | Genome Medicine | Q15816848 |
| P1476 | title | A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma | |
| P478 | volume | 6 | |